Clínica Médica

World Heart Federation afirma que nenhuma quantidade de álcool é boa para o coração.

25 Jan, 2022 | 11:51h

Comunicado de imprensa: No amount of alcohol is good for the heart, says World Heart Federation

Relatório: The Impact of Alcohol Consumption on Cardiovascular Health: Myths and Measures – World Heart Federation

Comentário: No amount of alcohol is good for the heart, new report says, but critics disagree on science – CNN

---

Diretrizes de prática clínica baseadas em evidências para dispepsia funcional.

25 Jan, 2022 | 11:48h

Evidence-based clinical practice guidelines for functional dyspepsia 2021 – Journal of Gastroenterology

Conteúdos relacionados:

Dyspepsia: A stepwise approach to evaluation and management.

UEG Consensus on Functional Dyspepsia.

Podcast: GERD and Dyspepsia

---

Perspectiva | Prevenção do “overdiagnosis” digital.

25 Jan, 2022 | 11:43h

Preventing Digital Overdiagnosis – JAMA (gratuito por período limitado)

Conteúdo relacionado: Overdiagnosis: it’s official – the term is now included in the medical subject headings (MeSH) vocabulary. (vários artigos sobre o tema)

---

Revisão | Intervenções para melhorar o conhecimento em saúde dos pacientes para prevenção secundária de doença arterial coronariana.

25 Jan, 2022 | 11:40h

Health literacy interventions for secondary prevention of coronary artery disease: a scoping review – openheart

---

Revisão | Distúrbios histiocíticos.

25 Jan, 2022 | 11:33h

Histiocytic disorders – Nature Reviews Disease Primers (se o acesso a este link for pago, tente este)

Infográfico: Histiocytic disorders (se o acesso a este link for pago, tente este)

 

Comentário no Twitter

Haemophagocytic lympho #histiocytosis is a syndrome of extreme #immune activation; common manifestations include involvement of the central nervous system, hepatitis or acute liver failure.https://t.co/heXWqru8wW pic.twitter.com/1A0SFIhkwR

— Nature Reviews Disease Primers (@DiseasePrimers) January 21, 2022

 

---

Comentário do KDOQI US sobre a Diretriz KDIGO 2021 para o tratamento da pressão arterial na doença renal crônica.

25 Jan, 2022 | 11:29h

KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Blood Pressure in CKD – American Journal of Kidney Diseases

Conteúdos relacionados:

KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease

Guideline synopsis: management of blood pressure in patients with chronic kidney disease not receiving dialysis.

 

Comentário no Twitter

The @nkf KDOQI work group agreed with most of the @goKDIGO BP recommendations while highlighting the weak evidence base especially for patients with diabetes and advanced CKD ca. 2022 #Nephpearls

👉🏼 https://t.co/X40N0pacY6 https://t.co/HEHlSD06yO pic.twitter.com/Rpil8m0QOn

— Edgar V. Lerma 🇵🇭 (@edgarvlermamd) January 21, 2022

 

---

Revisão clínica da semaglutida subcutânea para obesidade.

25 Jan, 2022 | 11:28h

Clinical review of subcutaneous semaglutide for obesity – Journal of Clinical Pharmacy and Therapeutics

---

Opinião | A COVID-19 vai continuar, mas o fim da pandemia está próximo.

21 Jan, 2022 | 16:02h

COVID-19 will continue but the end of the pandemic is near – The Lancet

 

Comentário no Twitter

.@IHME_UW's Chris Murray predicting the end of the pandemic is nigh
"More than 50% of the world will have been infected with omicron …[by] the end of March, 2022"
"After the omicron wave, COVID-19 will return but the pandemic will not."https://t.co/9NSw8lZuUe @TheLancet

— Eric Topol (@EricTopol) January 20, 2022

 

---

Europa considera uma nova estratégia contra COVID-19: aceitar o vírus.

21 Jan, 2022 | 16:00h

Europe considers new COVID-19 strategy: Accepting the virus – Associated Press

---

Perspectiva | Consequências da COVID-19 para o sistema nervoso.

21 Jan, 2022 | 15:57h

Nervous system consequences of COVID-19 – Science

Conteúdos relacionados:

Perspective | Post-acute neurological consequences of COVID-19: an unequal burden – “COVID-19 and its neurological consequences particularly burden marginalized communities, and so can only be effectively treated by advancing health equity”.

Review: Counting the neurological cost of COVID-19.

Infection with Covid-19 carries a much higher risk of developing neurological complications than Covid-19 vaccines.

M-A: Frequency of Neurologic Manifestations in COVID-19 – up to one-third of patients (89% hospitalized) experienced at least one neurological manifestation.

Neurological Effects of COVID-19 in Children.

Cohort study: Neurological manifestations of SARS-CoV-2 infection in hospitalized children and adolescents in the UK – “around 1 in 20 of children hospitalized with COVID-19 develop brain or nerve complications linked to the viral infection”.

International Registry: Ischemic and hemorrhagic stroke among critically ill patients with Covid-19.

Short review: Neurological complications of COVID-19.

2 new meta-analysis detail neurologic and psychiatric conditions in COVID-19.

M-A: Encephalitis as Neurological Complication of COVID‐19.

Large study finds 1 in 3 Covid-19 survivors have subsequent mental health and neurological conditionsEight out of ten people hospitalized with COVID-19 develop neurological problems – the most common self-reported symptoms included headache (37%) and anosmia or ageusia (26%).

[Preprint] Frequency of neurological manifestations in COVID-19: a systematic review and meta-analysis of 350 studies – up to one-third of COVID-19 patients analyzed in this review, 89% of whom were hospitalized, experienced at least one neurological manifestation

 

Comentário no Twitter

A new #SciencePerspective discusses the neurological symptoms that accompany #COVID19 and the possible mechanisms that cause them. Read more: https://t.co/WKZpnWlbNc pic.twitter.com/U4ohecaVQd

— Science Magazine (@ScienceMagazine) January 20, 2022

 

---